Sell Your Veterinary Practice in Oregon in 2026: 5-13x by Tier, PE Platforms, CPVM Structure

Selling your veterinary practice in Oregon in 2026 clears 5-7x EBITDA at the single-DVM lifestyle tier, 7-9.5x at 2-3 DVM general practice scale, 9.5-11.5x at the $1M-$3M EBITDA 4-8 DVM PE platform sweet spot (clean books to 12x), and 11-13x at $3M+ multi-doctor specialty scale. Portland and Eugene density supports platform-quality deals, plus Oregon 9.9% top capital gains rate shapes after-tax proceeds. Active Oregon buyers include Mars Veterinary Health, NVA/Ethos, Mission Pet Health, VetCor, PetVet Care Centers, Heartland.

Oregon sits at the western edge of one of the busiest consolidation lanes in animal health, and its own geography shapes what a practice here is worth. American Economic Liberties Project figures put cumulative private-equity investment in US veterinary at $51.6 billion across 2017-2023, with another $9.3 billion in the first four months of 2024 alone. What sets Oregon apart is that almost the entire buyer bench clusters on one axis: the Portland-Vancouver-Hillsboro metro, which held about 2.54 million people in 2024 (US Census Bureau estimate via USAFacts), anchors an I-5 corridor that runs south through Salem, Corvallis and Eugene, and Mars operates both Banfield and VCA hospitals across that metro. Over the Cascades, Bend and Central Oregon are growing fast but have no confirmed platform footprint, so where a practice sits inside the state does more to set the number of bidders than in most states.

This guide is written for the Oregon DVM who wants the price and the path. It walks through 2026 multiples by EBITDA tier, the wellness-plan premium that moves general-practice value most, the named consolidators with clinics already on Oregon ground, and the parts of an Oregon deal that differ from the national template: facility registration with the Oregon Veterinary Medical Examining Board under ORS 686, the fact that Oregon permits direct corporate ownership rather than banning it, the ORS 653.295 non-compete statute that is among the strictest in the country and reshapes how buyers hold doctors, and the Oregon tax picture, a 9.9% top rate on the gain with no sales tax, that decides how much of the check you keep.

CT Acquisitions runs confidential, buy-side processes. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing. For broader context, see our veterinary hub guide, our Private Equity in Veterinary 2026 report, our national guide to selling a veterinary practice, our specialty hospital guide, and our 36-month veterinary practice exit playbook. The free valuation survey takes about three minutes.

How Oregon veterinary practices are valued in 2026, the tiered framework

Oregon veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers use everywhere but read against a buyer pool that is deep on the Portland and I-5 corridor and thin east of the Cascades. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the point where corporate diligence pays for itself, so it usually sells between DVMs. Move up the tiers and the Willamette Valley metros start bidding.

Oregon veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers use everywhere but read against a bidder pool concentrated on the Portland and I-5 Willamette Valley corridor. A single-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the threshold where platform diligence pays for itself and typically clears 5x to 7x, changing hands between DVMs or small regional groups rather than going to a consolidator. A two-to-three-DVM general practice at $500K to $1M of adjusted EBITDA lands in the 7x to 9.5x range, with the top of that band earned by high-margin books that do not lean on one doctor. The four-to-eight-DVM hospital at $1M to $3M is where the valley platforms compete hardest and clears 9.5x to 11.5x, reaching 12x when the books are clean and a second-tier doctor bench is in place. Above $3M, usually a multi-doctor specialty or referral group, pricing runs 11x to 13x and can stretch to 16x to 18x for a marquee specialty hospital a buyer wants for geographic fill. Specialty, emergency and 24/7 hospitals carry a 1.5x to 3x premium over general practice. R.L. Hulett’s Q1 2025 Pet M&A Update reported closed transactions spanning 6x to 16x adjusted EBITDA, and per the American Economic Liberties Project private-equity buyers supplied roughly 80% of 2024 veterinary deal capital. A wellness-plan book above 15% of eligible general-practice cases routinely adds 0.5x to 1.5x on top of the size-tier baseline.

Oregon practice profile	Typical multiple	What moves it in Oregon
Single-DVM lifestyle / rural mixed-animal under $500K EBITDA	5-7x EBITDA	Below the platform diligence floor; sells DVM-to-DVM, common in the Coast Range, Eastern Oregon and the far south
2-3 DVM general practice ($500K-$1M EBITDA)	7-9.5x EBITDA	Draws Portland-metro and valley bidders even at modest scale
4-8 DVM hospital ($1M-$3M EBITDA)	9.5-11.5x EBITDA (clean books to 12x)	The tier Banfield, VCA, Thrive and VetCor compete for; associate bench and wellness penetration decide the top end
$3M+ EBITDA multi-doctor / specialty / referral	11-13x EBITDA (16-18x for marquee specialty)	Portland referral catchment carries it; specialty demand is centered on the metro
Multi-site groups (3+ hospitals)	12-15x EBITDA	Valley density commands platform-of-platform pricing

The lever that separates a floor multiple from a corridor multiple is competition. A four-doctor Portland-area hospital with $1.5M of EBITDA taken quietly to one strategic buyer might settle at 9.5x to 10.5x, roughly $14M to $16M. Run as a competitive process across the Mars hospitals, Thrive and VetCor that already operate in the metro, that same hospital pulls a second and third bidder to the table, and a buyer who marks tuck-ins up on its own balance sheet will pay one to two turns more to win the geography.

How does the wellness-plan / membership premium affect Oregon veterinary practice valuation?

For an Oregon general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Recurring monthly membership revenue turns transactional cash flow into something a buyer can underwrite as predictable, and every valley consolidator now expects it.

For an Oregon general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Practice-management software vendors put plan penetration above 18% of eligible patients nationally, and members spend two to three times what non-plan clients do, so a healthy book converts transactional cash flow into monthly recurring revenue that buyers value more highly because it smooths seasonality, signals retention, and supports a defensible lifetime-value calculation after close. Banfield built the model at scale with its Optimum Wellness Plans, and because Banfield runs several hospitals across the Portland metro its branded plan is already a familiar benchmark to Oregon clients. The groups buying in Oregon, from Mars under both Banfield and VCA to Thrive and VetCor, expect an acquired hospital to be on a branded plan within a year to eighteen months. The way to capture the premium in an Oregon process is to stand the plan up 18 to 24 months before going to market, push penetration past 12 to 15% of eligible general-practice cases, break the recurring revenue out as its own line in the financial pack, and carry it into the quality-of-earnings report as a distinct book. Oregon hospitals that arrive at market above 20% penetration and average member tenure past two years regularly clear 75 to 150 basis points above their size-tier baseline. The mirror image is the risk: a purely transactional Oregon practice with thin repeat visits gets marked down in the same diligence.

What do Oregon platform buyers underwrite regarding earnouts and DVM retention?

In Oregon deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention, not patient demand, so the structure leans on the seller and the associate bench staying put. Oregon’s unusually strict non-compete statute makes that retention harder to lock down, which pushes buyers toward equity rollover and earnouts rather than restrictive covenants.

In Oregon deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention rather than patient demand, so the structure leans on the seller and the associate bench staying put. A typical Oregon two-to-eight-DVM hospital sold to a platform closes on roughly 70 to 80% cash, with 10 to 20% rolled into equity in a Newco or platform holding company and 5 to 15% held as an earnout keyed to the selling doctor’s clinical hours through years one to three, associate retention through years one to two, and trailing-twelve EBITDA holding its baseline. Above $5M of enterprise value the rollover slice usually rises to 20 to 30%. The recurring fight is production-comp normalization: many Oregon owners run associate pay at 20 to 25% of production plus distributions, while platforms reset associates to 22 to 24% straight production with no profit share and then recompute adjusted EBITDA on that basis, so agreeing a ProSal floor with the buyer six to twelve months before signing heads off the haircut. Oregon adds a wrinkle that a buyer takes seriously: under ORS 653.295 an employee non-compete is void unless the doctor’s pay clears a yearly salary floor set by the Bureau of Labor and Industries, which rose to $119,541 for 2026, and the term cannot run past 12 months. Because associate non-competes are harder to enforce here than in most states, buyers lean on rollover equity, retention bonuses and the earnout rather than restrictive covenants to keep doctors, and a clawback typically fires if the selling DVM drops under 32 hours a week or under 80% of historical production for any 60-day window. Relief-doctor hours through IndeVets, Roo and similar staffing services generally do not count toward the production thresholds.

How much multiple expansion can you achieve through platform-versus-tuck-in arbitrage in Oregon?

The gap between what a platform pays for a single Oregon hospital and what that hospital is worth once it sits inside a larger group is why the buyers keep working the Portland metro and the I-5 valley. That spread is where the premium a seller can capture actually lives.

The gap between what a platform pays for a single Oregon hospital and what that hospital is worth once it sits inside a larger group is why the buyers keep working the Portland metro and the Willamette Valley. A standalone four-doctor Oregon general practice at $1.5M of EBITDA sold direct might clear 9.5x to 10.5x. Tucked into a group that itself trades at a 15x to 18x platform multiple, the same earnings get re-marked at five to seven turns higher on the acquirer’s books, which is why groups such as Thrive, VetCor and the Mars hospital networks will pay 11x to 12x for a $1M to $2M Oregon hospital they want. The catch for an Oregon seller is that the premium only shows up when the buyer actually wants the geography or species mix. An off-thesis hospital, wrong corner of the state, wrong case load, or soft earnings quality, gets the floor multiple regardless of how many platforms exist. That is where the corridor helps: because several buyers already operate inside the Portland metro and down the valley, an Oregon owner on the I-5 spine who runs four to six of them in parallel is far more likely to find the one for whom the practice is on-thesis, and to convert that into one or two extra turns. A seller in Bend or Eastern Oregon has fewer natural bidders and has to work harder to manufacture the same tension. Tighter acquisition-debt markets through 2024 and 2025 trimmed platform multiples by a turn or two from the 2021-2022 peak, and the late-2025 rate cuts have restarted committed financing, which is part of why Oregon buyers are active again in 2026.

Who is buying Oregon veterinary practices in 2024-2026, named platforms with CURRENT ownership

The Oregon buyer pool is the national buyer pool with its Portland-metro members already on the ground. It splits into Mars permanent capital, roughly 15 private-equity-backed national platforms, and the doctor-controlled alternatives, with Mars the most visible presence in the state through its Banfield and VCA hospitals.

The Oregon buyer pool is the national buyer pool with several of its members already operating inside the state. It splits into Mars permanent capital, roughly 15 private-equity-backed national platforms, and the doctor-controlled alternatives. Mars Veterinary Health is the largest and the most visible on Oregon ground, folding VCA, Banfield and the BluePearl specialty and emergency network under one strategic, permanent-capital umbrella rather than a fund; per the CT Acquisitions Oregon buyer ledger Mars runs multiple Banfield hospitals across the Portland metro, including NE 82nd Avenue, the NW 20th Place uptown location, the West Hills, Sellwood-Moreland and Cedar Mill, plus VCA hospitals at Raleigh Hills, North Portland on Lombard and Southeast Portland. NVA sits under JAB Holding Company with its Ethos specialty and emergency division, and the 2022 FTC consent order from the SAGE deal still restricts JAB specialty and ER acquisitions within 25 miles of an existing JAB clinic in California and Texas. Mission Pet Health, backed by Shore Capital Partners, reached roughly 750 clinics after the July 2025 merger of Mission Veterinary Partners and Southern Veterinary Partners. VetCor is led by Oak Hill Capital with Harvest Partners and Cressey & Co. and, per the same ledger, operates in the Portland metro. Thrive Pet Healthcare, owned by TSG Consumer Partners, runs confirmed Portland-metro sites including a community hospital serving Tigard, Beaverton and Tualatin and the Powell Veterinary Center. PetVet Care Centers has been owned by KKR since 2022 (not Onex). Heartland Veterinary Partners is now a Gryphon Investors majority after its 2024-2025 recap (not American Securities), and AmeriVet is held by AEA Investors and the Abu Dhabi Investment Authority since the February 2022 recap (not Imperial Capital). Other national platforms in the pool include Veterinary Practice Partners (Audax), Innovetive Petcare (Metalmark), United Veterinary Care (Nordic Capital, not Atlantic Street), Suveto (Levine Leichtman, not LongueVue), Veritas (Percheron), Encore Vet Group (North Castle), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus urgent care), VetEvolve (Varsity Healthcare) and Pieper Veterinary (Chicago Pacific Founders). The doctor-controlled route is real in Oregon too: MedVet is roughly 95% DVM and employee owned with a Leonard Green minority, and Galaxy Vets is the first US consolidator built as an employee stock ownership plan, both genuine options for an owner who wants liquidity without handing clinical control to a fund.

How are different veterinary sub-verticals valued in Oregon?

Buyers rank Oregon veterinary sub-verticals on a clear hierarchy. General practice is the backbone of the platform thesis; specialty and referral sit at the top of the multiple range, and demand for both concentrates on the Portland metro.

Buyers rank Oregon veterinary sub-verticals on a clear hierarchy. General practice is the backbone of the platform thesis at 5x to 12x adjusted EBITDA by size, with buyers favoring two-to-eight-DVM hospitals that carry a stable associate bench, own or control their real estate, and run a wellness book. Specialty and referral practices, covering surgery, internal medicine, oncology, cardiology, neurology, dermatology and ophthalmology, trade highest at 11x to 14x and up to 16x to 18x for a marquee multi-specialist hospital with strong referral catchment; in Oregon that demand is centered on Portland, where BluePearl under Mars and independent referral centers compete for the same cases, so a metro specialty seller faces real bidding rather than a thin market. Emergency, urgent-care and 24/7 hospitals carry 11x to 13x on the scarcity of overnight staffing and the specialty cross-sell. Mixed-animal, equine and food-animal practices, more common in the Willamette Valley farm belt, Eastern Oregon and the ranch country, are a separate buyer pool at 5x to 8x, since production-animal economics, travel logistics and USDA APHIS oversight do not standardize well at platform level and the buyers tend to be other large-animal DVMs or regional groups. Mobile and house-call practices are capital-light but doctor-time-bound with little platform appetite because there is no real-estate moat. Multi-site groups of three or more hospitals are the single most attractive Oregon archetype, since valley density gives buyers a pipeline of further tuck-ins, and they pay platform-of-platform multiples of 12x to 15x for it.

Our national data on veterinary practice valuation multiples shows what buyers actually pay by tier.

What is the Oregon veterinary market context in 2026?

Oregon permits a non-veterinarian or corporation to own a practice outright under ORS 686, provided the facility registers with the board and designates a licensed Oregon veterinarian for clinical care. Demand concentrates on the Portland metro and the I-5 Willamette Valley, with Oregon State’s vet school in Corvallis feeding the in-state doctor pipeline.

Oregon permits a non-veterinarian or corporation to own a veterinary practice outright rather than banning it, which is the first thing that separates it from restricted states like New York or Idaho. Under ORS 686 a veterinary facility may operate so long as it registers with the Oregon Veterinary Medical Examining Board and names a licensed Oregon managing veterinarian who is accountable to the board for clinical compliance, and board rule OAR 875-015-0005 sets out that managing-veterinarian duty. Oregon even lifted its old clinic-ownership limit specifically to allow non-veterinarian and corporate ownership (VIN News), so most Oregon deals proceed without the friendly-PC-plus-management-company scaffolding that restricted states require. Demand concentrates where the people and the doctors are. The Portland-Vancouver-Hillsboro metro held about 2.54 million people in 2024 (US Census Bureau estimate via USAFacts) and is the deepest buyer market in the state, with Salem at roughly 443,000, Eugene-Springfield at about 382,000 and Bend at about 266,000 trailing it down and across the valley. Oregon State University’s Carlson College of Veterinary Medicine in Corvallis, the state’s only DVM program, seats roughly 96 students a year, about half of them Oregon residents, which feeds a modest in-state associate pipeline that lowers the staffing risk buyers weigh most heavily near the metros. Bend and Central Oregon are among the fastest-growing parts of the state but sit three-plus hours over the Cascades from the valley bench, so buyers price the I-5 corridor more aggressively than the high desert.

Which buyers are actually near your Oregon practice, and what your location does to your negotiating position

One real buyer market on the Portland/I-5 Willamette Valley corridor; a fast-growing but platform-thin Bend/Central Oregon pocket over the Cascades.

• Banfield Pet Hospital (Mars Veterinary Health): Portland (NE 82nd Ave), Portland (Uptown / NW 20th Pl), Portland (West Hills), Portland (Sellwood-Moreland), Portland (Cedar Mill)
• VCA Animal Hospitals (Mars Veterinary Health): Portland (VCA Raleigh Hills, 4905 SW 77th Ave), Portland (VCA North Portland, 3000 N Lombard St), Portland (VCA Southeast Portland)
• Thrive Pet Healthcare (TSG Consumer): Portland metro (Community Pet Hospital, serving Tigard / Beaverton / Tualatin), Portland (Powell Veterinary Center)
• VetCor (Cressey & Co / Harvest): Portland (per internal ledger)

Your location scored on five factors

Proximity to an existing platform is the hook, but it only converts if you clear the size bar, and three more factors, metro depth, DVM labor supply, and the demand trend, decide how hard buyers actually compete. Here is how Oregon reads on all five.

Factor	What it means for your exit
Buyers near you	Portland metro (~2.27M) has a real, previously-understated platform bench – Mars runs BOTH Banfield and VCA hospitals across the metro and Thrive operates confirmed Portland-metro sites (VetCor per ledger) – and that reach extends down the ~2-hour I-5 valley through Salem, Corvallis and Eugene; Bend/Central Oregon, 3+ hours over the Cascades, has no confirmed platform footprint and is a scarcity market.
Your size gate	On the Portland/valley corridor a buyer can absorb even a solid solo or small multi-DVM practice as a tuck-in, so the relative scale bar is lower; in isolated Bend the bar rises because a buyer must stand the practice up standalone and solve staffing, unless a strong growth/differentiation story pulls it back down.
Metro depth	Portland (~2.27M, large) anchors the only genuine multi-bidder metro in the state with Salem/Corvallis/Eugene inside the same ~2-hour valley; Bend-Redmond (~265K) is a fast-growing but thin, one-to-few-bidder market.
DVM labor supply	Oregon State’s Carlson College of Veterinary Medicine in Corvallis is the in-state DVM pipeline (~72/class) feeding the Willamette Valley corridor and lowering corridor staffing risk, though its modest class size makes it a real but not overwhelming tailwind; the advantage does not travel over the Cascades to Bend.
Demand trend	Portland’s affluent ‘Silicon Forest’ economy and intense PNW dog-friendly culture drive durable premium wellness demand on the corridor, while Bend/Deschutes is Oregon’s fastest-growing county (~213K, ~97% from in-migration), a distinct affluent-growth pocket – both are tailwinds, the corridor’s denser and Bend’s faster.

If you are anywhere on the Portland metro or the I-5 Willamette Valley corridor (Portland, Salem, Corvallis, Eugene), you sit inside a real buyer market that the raw data understates: Mars operates both Banfield and VCA hospitals across Portland, Thrive runs confirmed Portland-metro locations, and VetCor is present per the ledger, all within a single continuous roughly two-hour market down the valley. Each of those buyers can slot your practice into an existing cluster, so proximity here is genuine bargaining position and can produce real bidder tension on a clean, multi-DVM practice. But proximity is gated by your scale. On the corridor that gate is relatively low: a buyer can absorb even a solid solo or small multi-DVM practice as a tuck-in with little marginal overhead. Push over the Cascades to Bend and the gate rises sharply. Bend is three-plus hours from Portland over weather-exposed passes, has no confirmed platform footprint, and a buyer there is planting a standalone flag rather than extending a cluster, so a sub-scale Bend practice will struggle to attract institutional attention and is more likely to sell to a local or regional buyer.

MSA depth backs the corridor story: Portland is the only genuine multi-bidder metro in the state, with Salem, Corvallis and Eugene inside the same two-hour valley, while Bend-Redmond is a thin, one-to-few-bidder market. Labor is a real but measured tailwind on the corridor. Oregon State’s Carlson College of Veterinary Medicine in Corvallis is the in-state DVM pipeline and sits dead-center in the valley, which lowers a buyer’s biggest worry (staffing the practice after the founder slows down); its class of roughly seventy is modest, so it helps without being a labor firehose, and its benefit does not cross the Cascades to Bend. Demand is a tailwind on both poles for different reasons: Portland’s affluent Silicon Forest economy and intense PNW dog culture drive durable premium wellness spend, and Bend is Oregon’s fastest-growing, affluent-in-migration pocket, which is a genuine growth story a buyer will pay for even without cluster synergy.

Two Oregon-specific structural facts frame the deal. First, tax is a real drag: Oregon’s top rate is 9.9% and it taxes capital gains as ordinary income with no preferential long-term rate, so a large practice-sale gain gets hit hard at the state level, only modestly softened by Oregon having no general sales tax. Model your net proceeds accordingly. Second, the non-compete regime cuts in your favor on structure but not on your own covenant: ORS 653.295 makes ordinary EMPLOYMENT non-competes hard to enforce (two-week pre-hire notice, twelve-month cap, a roughly $116K-$120K salary floor, exempt-only, thirty-day copy rule), so your associate DVMs are highly mobile and buyers lean on long employment agreements, retention bonuses and earn-outs rather than covenants to keep them; but that statute governs the employer-employee relationship, not the bona-fide SALE of your business, so as the selling owner you can still be bound to a normal goodwill-based sale non-compete. Net: Portland-corridor Oregon combines strong (and underrated) proximity, a low size gate, the state’s only deep MSA, a solid-if-modest OSU labor pipeline and a real demand tailwind – a genuinely seller-friendly market, tempered by a meaningful capital-gains tax drag. Bend is a fast-growth scarcity play that rewards a differentiated, well-run practice and punishes a sub-scale one.

What should Oregon veterinary sellers know about the ownership rules, facility registration, and FTC scrutiny?

Selling an Oregon veterinary practice touches three regulatory layers, but the first is friendlier here than the national template assumes: Oregon does not bar non-veterinarian ownership. The layers are OVMEB facility registration, federal DEA registration, and the antitrust backdrop.

Selling an Oregon veterinary practice touches three regulatory layers, and the first is friendlier here than the national template assumes. Many states restrict or prohibit non-veterinarian ownership and force private-equity buyers into a management-services-organization structure where a friendly DVM holds the practice while a company owned by the sponsor provides administration under a long-term services agreement. Oregon is not one of those states. Under ORS 686 a corporate or non-veterinarian owner may hold the practice outright, provided the facility registers with the Oregon Veterinary Medical Examining Board and designates a licensed Oregon managing veterinarian accountable to the board for clinical compliance, so most Oregon buyers can own the practice directly and usually avoid the $50K to $150K of extra structuring cost a restricted-state friendly-PC arrangement adds. What Oregon does require is attention to the facility registration itself: a facility registration terminates on a change of ownership rather than carrying over, so the registration cannot simply be assigned, and the new owner registers the facility fresh and names its managing veterinarian as part of closing (OVMEB facility registration rules). The second layer is federal and unchanged by state law: each location that stores or dispenses controlled substances needs its own DEA registration, the new owner obtains a fresh DEA number, the controlled-substance inventory transfers with a documented count signed by both sides at close, and Schedule II drugs move on DEA Form 222. The third layer is antitrust posture. The 2020 NVA / Compassion-First and 2022 JAB / SAGE FTC consent orders remain in force, the May 2024 FTC and DOJ request for information named veterinary roll-ups as a concern, and a January 2025 FTC settlement signaled that stealth sub-HSR acquisitions in fragmented healthcare verticals are on the agenda, so a deal where the likely Oregon buyer already owns nearby specialty or ER capacity can draw a longer review.

How this applies to an Oregon veterinary practice sale

For an Oregon seller the sequence is shorter than in a restricted state. First, ownership: because Oregon allows corporate ownership with a designated managing veterinarian, the deal usually does not need a friendly-PC-plus-management-company workaround, which removes a cost and a delay that New York or Idaho sellers cannot avoid. Second, the facility registration: because it terminates on the ownership change, the buyer files a new OVMEB facility registration and names the managing veterinarian, and this belongs on the closing checklist rather than being treated as an automatic transfer. Third, DEA: the new owner secures a fresh DEA registration, the controlled-substance inventory transfers with a signed count, and Schedule II items move on Form 222, with the Oregon Board of Pharmacy registration updated in parallel. Fourth, antitrust: if the most likely platform bidder already holds specialty or emergency capacity near you, in the Portland metro especially, build extra review time into the calendar. Plan on roughly 90 to 150 days from signing to close, with the DEA reissuance and, in the metro, any FTC look as the constraints that actually set the pace.

What deal mechanics are specific to Oregon veterinary practice sales?

The deal mechanics on an Oregon veterinary sale follow the national pattern with two Oregon-specific bends: non-compete enforceability runs on ORS 653.295, one of the strictest statutes in the country, and the ownership-transfer step is a fresh facility registration rather than a corporate-practice workaround.

The deal mechanics on an Oregon veterinary sale follow the national pattern with a couple of Oregon-specific bends. Rollover equity typically runs 20 to 30% of proceeds into a Newco or platform holding company on deals above $5M of enterprise value, vesting over three to five years and monetizing at the next recap on a four-to-six-year hold. The DVM-retention earnout holds 5 to 15% of consideration against the seller’s continued clinical hours, associate retention through years one to two, and EBITDA stability, with a clawback if the seller falls under 32 hours a week or under 80% of pre-close production for any 60-day window. Production-comp normalization is the same recut buyers apply everywhere: associates reset to 22 to 24% straight production and adjusted EBITDA is recomputed on that basis, which can trim it 5 to 15% unless the seller pre-empts it. The first Oregon-specific point is non-competes. ORS 653.295 is among the toughest in the nation: an employee non-compete entered after a 2021 amendment (Senate Bill 169) is void, not merely voidable, unless the employer gives at least two weeks’ written notice before hire or a bona fide advancement, the employee is exempt and earns above a yearly salary floor the Bureau of Labor and Industries indexes each year (it rose to $119,541 for 2026), and the term runs no longer than 12 months. A non-compete given by a selling owner as part of the sale of a business is treated far more favorably and generally holds, so buyers rely on the sale-of-business covenant from the owner while leaning on rollover equity and retention bonuses rather than associate covenants to keep the bench. The second Oregon-specific point is the ownership transfer: instead of restructuring around a corporate-practice ban, the parties let the old facility registration terminate at closing and the new owner files a fresh OVMEB registration naming the managing veterinarian. Real estate is commonly split into a separate entity at signing and leased back on a 15-to-20-year triple-net lease, leaving veterinary real estate as independent optionality at roughly 5.5% to 7.5% cap rates.

Why is the DVM succession crisis driving Oregon veterinary owners to sell now?

The engine behind the Oregon selling wave is succession, not a doctor shortage. The AAVMC projects enough new graduates to meet aggregate demand, so the real driver is an aging pool of practice owners deciding to step back, and Oregon has a large cohort reaching that decision now.

The engine behind the Oregon selling wave is succession, not a doctor shortage. The 2025 AVMA Report on the Economic State of the Veterinary Profession counts roughly 130,415 DVMs in the US workforce, most in small-animal practice, and the AAVMC 2024 supply-and-demand study concluded that new graduates from existing colleges should meet aggregate demand through the mid-2030s, with real shortfalls concentrated in rural, food-animal and emergency staffing rather than across the board. The more durable driver is demographic. Peer-reviewed survey work published in JAVMA over 2024 and 2025 found that 61% of clinical-practice DVMs intend to cut clinical hours within five years and 31% intend to stop clinical work entirely, and roughly 8% of working veterinarians are already 66 or older. Oregon feels this on two sides at once: its metro practices sit near Oregon State’s Corvallis graduate pipeline that keeps associate supply steadier than in no-school states, while its large base of owner-operators who built practices in the 1980s and 1990s is now reaching retirement. Rural Oregon, the Coast Range, Eastern Oregon ranch country and the far south, feels the owner-age squeeze harder because the OSU pipeline does not reliably travel there. With private-equity capital restarted by the late-2025 rate cuts and buyers already positioned along the Portland and I-5 corridor, 2026 through 2030 is the structural window when more Oregon owners cross 60 than at any prior point.

Why an Oregon veterinary practice sale needs vertical-specific advice

A generalist advisor who treats an Oregon veterinary practice as any other services business will miss the levers that move the price and will misread the Oregon rules, most importantly by assuming a corporate-practice ban that Oregon does not have and by underweighting how strict Oregon’s non-compete law is.

A generalist advisor who treats an Oregon veterinary practice as any other services business will miss the levers that move the price and will misread the local rules. The wellness-plan documentation, the rollover-equity slice that monetizes at the next recap, the 5 to 15% production-comp recut buyers apply to pre-close numbers, the 32-hour and 80%-production earnout thresholds, and the split between an enforceable sale-of-business non-compete and a far more contestable associate covenant are all veterinary-specific diligence items. Two of them are Oregon-specific. The first is that Oregon permits corporate ownership through facility registration under ORS 686, so an advisor who reflexively builds a friendly-PC-plus-management-company structure adds cost and delay the deal does not need. The second is that Oregon non-competes run on ORS 653.295, one of the strictest statutes in the country, which changes how you value doctor retention and pushes the retention economics into equity and bonuses rather than covenants. An Oregon seller working with someone who knows the current platform cap tables, which buyers already sit in the Portland metro and valley, and how Oregon actually registers facilities and enforces non-competes, negotiates as an equal rather than being educated by the buyer’s diligence team at their own expense.

What is the 18-24 month pre-sale playbook for Oregon veterinary practices?

Oregon owners who reach the top of their tier prepare deliberately over 12 to 24 months. The priorities are the wellness book, a real associate bench, clean normalized earnings, a facility-registration plan that accounts for the termination-on-sale rule, and using the Portland metro and valley to run a genuine competitive process.

Oregon owners who reach the top of their tier almost always prepared deliberately. With 12 to 24 months of runway, work down this list:

• Stand up a wellness plan 18 to 24 months out. Push penetration past 12 to 15% of eligible cases, break recurring revenue out in the financials, and carry it into the quality-of-earnings report; in an Oregon process this one move can add 75 to 150 basis points over the size-tier baseline.
• Move associates to ProSal six to twelve months before signing. Pre-empting the platform production-comp reset neutralizes the 5 to 15% EBITDA haircut buyers otherwise apply.
• Build the associate bench. A single-DVM practice sits below the platform floor; getting to two or three doctors reaches 7x to 9.5x and four to eight reaches the 9.5x to 11.5x tier, and near Portland and Corvallis the Oregon State pipeline makes hiring that bench realistic.
• Normalize owner compensation. Set owner W-2 and production at market and let the excess fall to EBITDA, documented in payroll and K-1 detail before diligence starts.
• Plan the facility re-registration and DEA transfer. Because an Oregon facility registration terminates on a change of ownership, map the buyer’s fresh OVMEB registration and managing-veterinarian designation, a clean board record, and an accurate Schedule II inventory before you go to market.
• Draft the sale-of-business non-compete carefully, and do not over-rely on associate covenants. Under ORS 653.295 associate non-competes are void unless they clear the salary floor, the notice rule and the 12-month cap, so lean on the owner’s sale-of-business covenant plus retention economics to reassure a buyer on doctor continuity.
• Decide on the real estate. Carving the building into a separate entity and leasing it back on a long triple-net at market rent creates independent optionality at roughly 5.5% to 7.5% cap rates.
• Use the corridor. Because several platforms already operate in the Portland metro and down the I-5 valley, run four to six of them in parallel rather than taking the first inbound offer; competition is what converts proximity into price.

For the broader framework, see our Private Equity in Veterinary 2026 report, our 36-month veterinary exit playbook, and the lower middle market buyer mandate report.

What are the most common mistakes Oregon veterinary practice owners make when selling?

The mistakes that cost Oregon sellers money cluster around anchoring on revenue, missing the production-comp recut, chasing outdated buyer lists, over-relying on associate non-competes Oregon will not enforce, and taking the first offer when the metro gives them a real auction.

• Anchoring on revenue instead of adjusted EBITDA, doctor-retention structure and wellness-plan penetration, which are what buyers actually pay for.
• Not modeling the production-comp recut. Platforms reset associates to 22 to 24% straight production and recompute EBITDA, a 5 to 15% cut that is routine unless you pre-empt it.
• Working an outdated buyer list. PetVet is KKR (not Onex), Heartland is Gryphon (not American Securities), AmeriVet is AEA and ADIA (not Imperial Capital), United Veterinary Care is Nordic Capital (not Atlantic Street), and Suveto is Levine Leichtman (not LongueVue); outreach to stale cap tables wastes runway.
• Assuming Oregon bans corporate ownership. It does not; ORS 686 permits it with a designated managing veterinarian, and building a friendly-PC-plus-management-company structure the deal does not need adds cost and delay rather than protection.
• Over-relying on associate non-competes. Under ORS 653.295 they are void unless they clear the salary floor, the notice rule and the 12-month cap, so a retention plan built on covenants rather than equity and bonuses can fall apart.
• Overlooking the doctor-controlled route. MedVet, roughly 95% DVM and employee owned, and Galaxy Vets, built as an ESOP, are genuine Oregon-accessible options for owners who want liquidity without handing clinical control to a fund.
• Taking the first inbound offer. With multiple platforms in the Portland metro and down the valley, a confidential competitive process typically lifts terms by one to two turns of EBITDA over a single-bidder negotiation.

Sell Your Veterinary Practice: Oregon and beyond

These companion guides go deeper on the national buyer pool, the valuation math, and the exit timeline that an Oregon sale plugs into.

Companion guides for Oregon sellers:

• Sell Your Veterinary Practice / Animal Hospital (national overview)
• Private Equity in Veterinary 2026: Active Platforms, Multiples, and Consolidation
• How to Sell a Veterinary Practice 2026
• Selling a Veterinary Specialty Hospital in 2026
• How to Prepare Your Veterinary Practice for a Sale or Exit (2026)
• How to Buy a Veterinary Practice in 2026 (Buyer’s Playbook)
• The lower middle market buyer mandate report
• Exit multiple: the 2026 operator’s guide

Oregon veterinary practice sale: 2026 outlook and key takeaways

Veterinary is one of the deepest consolidation pools in healthcare-adjacent services, and Oregon is a solid seat in it even though its buyer bench is narrower than a Midwest corridor state. Cumulative private-equity investment reached $51.6 billion over 2017-2023 with another $9.3 billion in early 2024 (American Economic Liberties Project), 15-plus national platforms compete alongside Mars permanent capital, and a structural seller wave is building as 61% of clinical-practice DVMs plan to cut clinical hours within five years (JAVMA 2024-2025). An Oregon hospital with four to eight doctors, wellness penetration past 12 to 15%, normalized production comp, a clean path to fresh OVMEB facility registration and a new DEA number at closing, clean real-estate optionality, and a sale-of-business non-compete drafted to survive ORS 653.295 can realistically reach the upper end of its 9.5x to 11.5x tier, with multi-site groups reaching 12x to 15x. The things that most often cost Oregon sellers money are an unprepared production-comp recut, outreach to stale buyer lists, over-reliance on associate non-competes Oregon will not enforce, ignoring the antitrust look in the Portland metro, and accepting the first offer instead of running the corridor as the competitive process it can be.

This guide reflects 2026 veterinary M&A conditions and CT Acquisitions’ direct work with active acquirers. Multiples are directional, not a guarantee; every practice is underwritten on its own doctor roster, wellness-plan penetration, adjusted EBITDA, real-estate optionality and growth profile. Oregon veterinary facility registration under ORS 686 and OAR chapter 875, Oregon Veterinary Medical Examining Board managing-veterinarian and ownership-change rules, DEA registration transfer, Oregon non-compete standards under ORS 653.295 and the BOLI salary threshold, the 2022 FTC JAB / SAGE consent order, the May 2024 FTC / DOJ serial-acquisitions RFI, and Oregon tax provisions are all subject to change; confirm current requirements with qualified Oregon veterinary counsel before relying on them in a transaction.

Related sale guides for Oregon sellers

If you operate a different business in Oregon, our state-specific sub-guides walk through the named PE buyers, current valuation multiples, and Oregon-specific deal mechanics for each vertical. You can also explore veterinary practice sales in other high-activity states.

Other Oregon industry sale guides

• Sell a CPA / accounting firm in Oregon
• Sell a RIA / wealth management firm in Oregon
• Sell an insurance agency in Oregon
• Sell a managed IT / MSP business in Oregon
• Sell a Commercial HVAC business in Oregon
• Sell Your Oregon Business (state hub with all verticals)

Veterinary practice sales in other states

• Texas
• California
• Florida

Oregon veterinary practice sale: frequently asked questions